Novel Strategies for Innovating Deceased Donor Procurement
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 2
- 试验地点
- 2
- 主要终点
- Sequence of organ procurement
研究概览
简要总结
Despite many efforts to increase the size of the donor pool, there is a large and growing disparity between the number of donor kidneys available for transplantation and the number of patients on the transplant waiting list. Increasing the quality of currently available donor kidneys would potentially improve the longevity of deceased donor kidney transplants by years, thus increasing the rate of transplantation patients on the kidney transplant waiting list. In addition, recipients of higher quality kidneys have shorter hospital stays and lower total hospital charges. By innovating the organ donation process, such that deceased donor kidneys are removed prior to the cessation of cardiac activity, rather than after, it may be possible to improve the quality of the kidney before transplantation, resulting in improved function after transplantation and increased longevity of these transplanted kidneys. Further, this improved kidney quality is highly likely to translate to reduced need for renal dialysis and other high-cost interventions, yielding lower total hospital charges. In this study we will test the hypothesis that, through a cost-free technical innovation, the quality of deceased donor kidneys could be improved significantly, saving thousands more lives per year and reducing total health care expenditures on renal transplantation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Currently listed to receive a deceased donor kidney transplant
- •Able to fully understand the informed consent document
- •Recipient over the age of 18 years
排除标准
- •Recipients undergoing a bilateral native nephrectomy at time of transplant
- •Recipients undergoing dual (liver-kidney, kidney-pancreas, pediatric en bloc) transplant
- •Individuals who are unable to understand the informed consent document
- •Recipient under age 18 years
- •Recipients receiving desensitization protocols for high levels of donor specific antibodies
结局指标
主要结局
Sequence of organ procurement
时间窗: 1 year
Renal allograft survival
Kidney quality
时间窗: 3 months
Incidence of delayed renal graft function
次要结局
未报告次要终点
研究者
Joseph Scalea
Assistant Professor of Surgery Director of Pancreas and Islet Cell Transplantation
University of Maryland, Baltimore
